Minnesota medical marijuana patients are worried after news broke that one of the state’s two cannabis providers is experiencing a distribution delay, leaving them with scarce supplies for treatment.
Tag Archives: Leafline Labs
Minnesota’s two licensed medical marijuana manufacturers have lost a combined $11 million in just two years of sales, according to financial documents obtained by the Associated Press
In Minnesota, medicinal cannabis companies and the state’s health commissioner disagree with the state Veterans Affairs regarding the use of medical marijuana for PTSD. The controversy centers around the commissioner’s decision to include PTSD among the conditions that qualify for medical marijuana, while Veterans Affairs prohibits its use.
ST. PAUL, Minn. — Minnesota’s two licensed medical marijuana manufacturers each posted millions of dollars in losses in their first full year of operations, according to financial documents obtained by The Associated Press.
Medical-marijuana startup LeafLine Labs has begun an effort to raise $21 million, according to a regulatory filing.
Minnesota is one of the most tightly regulated marijuana states in the United States at the moment. Only two licenses were approved for the entire state last year to serve the country’s first legislatively defined “smokeless state.”
A Minnesota health official instrumental in getting the state’s medical marijuana program off the ground is leaving to become chief executive of one of the two marijuana producers in the state.
When medical marijuana becomes available in Minnesota on July 1, two state-approved companies will begin selling cannabis in pill and oil form to patients who suffer from cancer, HIV, AIDS, ALS and other conditions.